A new type of “educational” service has been brought to our attention that uses virtual reality (VR) systems allowing a number of opportunities for men to “talk” to a virtual prostate cancer patient about their own risks for prostate cancer and things like the risks and benefits of PSA testing. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: knowledge, patient, risk, testing, Treatment, virtual | 3 Comments »
An article published in Communications Biology has suggested that all prostate cancer patients should be routinely tested fro risk of infection with COVID-19. This appears to be a questionable piece of advice for the average prostate cancer patient. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: COVID-19, risk, testing | Leave a comment »
The recommendations of the Philadelphia Prostate Cancer Consensus Conference 2019 (held in October last year) on implementation of germline testing for risk of prostate cancer have now been published in the Journal of Clinical Oncology. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: consensus, germline, risk, somatic, testing | 1 Comment »
A newly published paper has now suggested that data from a single PSA test carried out when the men are between 40 and 64 years of age can be used to project risk for aggressive prostate cancer among African-American men. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: African=American, black, PSA, risk, testing | 2 Comments »
A recent report from the Prostate Cancer Foundation (PCF), here in the US, found — unsurprisingly to your sitemaster, at least — that the average American remains very poorly informed about risk for prostate cancer and associated issues. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: education, public, risk, screening, testing | 2 Comments »
A new and potentially controversial article in Urology (the “Gold Journal”) has just suggested that regular, mass, population-based screening of men for risk of prostate cancer every 12 to 18 months remains a good idea. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Management, PSA, risk, screening, testing | 9 Comments »
… and during Prostate Cancer Awareness Month men and their families are regularly subjected to messaging about the importance of getting “screened” for risk of prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: risk, screening, testing | 4 Comments »
Data from a new study reported in the British Medical Journal discusses a “polygenic hazard score” that can potentially be used to guide screening for aggressive prostate cancer (but only in men of European ancestry at this time). … READ MORE …
Filed under: Diagnosis, Risk | Tagged: aggressive, data, genetic, genomic, predict, risk, testing | 2 Comments »
Knowing whether you carry inherited cancer risk genes can help you to make the best decisions for your treatment and for your family. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: counseling, genetic, medicine, precision, testing | 1 Comment »
The European Association of Urology (EAU) “Update on Prostate Cancer” meeting was held in Vienna, Austria, on Friday and Saturday, and Dr. Zachary Klaassen was again busy providing summary reports on presentations for UroToday. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: active surveillance, Diagnosis, PSA, screening, staging, testing | Leave a comment »
Yesterday we mentioned a new paper on PSA screening by Tsodikov et al. in the Annals of Internal Medicine. We have now had the chance to read the full text of that paper, as well as the associated editorial by Vickers in the same issue of the journal. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: mortality, PSA, risk, screening, testing | 5 Comments »
A new article just published in the Annals of Internal Medicine has suggested that PSA testing really does save lives. But the new article isn’t based on any really new data. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: PSA, screening, testing | Leave a comment »
To quote the abstract of the paper discussed below, the use of the PSA test to screen for risk of prostate cancer “in men at normal risk of prostate cancer is one of the most contested issues in cancer screening.” No! Really? … READ MORE …
Filed under: Diagnosis, Risk | Tagged: benefit, diagosis, PSA, risk, screening, testing | 3 Comments »
What isn’t as big a deal as we might think? According to The New York Times this morning, the US Preventive Services Task Force’s new recommendations about prostate cancer screening. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: Diagnosis, risk, screening, testing | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 